Stay updated on Nab-Paclitaxel/Gemcitabine±Olaratumab in Metastatic Pancreatic Ca Clinical Trial

Sign up to get notified when there's something new on the Nab-Paclitaxel/Gemcitabine±Olaratumab in Metastatic Pancreatic Ca Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nab-Paclitaxel/Gemcitabine±Olaratumab in Metastatic Pancreatic Ca Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    The footer revision identifier changed from v3.7.1 to v3.7.2 on the 403 Forbidden page.
    Difference
    0.2%
    Check dated 2026-10-19T21:45:08.000Z thumbnail image
  2. Check
    12 days ago
    Change Detected
    Summary
    The site footer revision changes from v3.7.0 to v3.7.1 while the page continues to display a 403 error.
    Difference
    0.2%
    Check dated 2026-10-13T04:14:14.000Z thumbnail image
  3. Check
    19 days ago
    No Change Detected
  4. Check
    33 days ago
    Change Detected
    Summary
    The study page now shows a 403 error instead of the full study record, replacing the detailed trial information with an error screen. The content that users expect (title, sponsor, locations, and criteria) is not displayed.
    Difference
    20%
    Check dated 2026-09-21T22:04:09.000Z thumbnail image
  5. Check
    55 days ago
    Change Detected
    Summary
    The page's revision tag updates to v3.6.6, replacing the previous v3.6.5 to reflect a newer site build.
    Difference
    0.0%
    Check dated 2026-08-31T16:15:58.000Z thumbnail image
  6. Check
    62 days ago
    Change Detected
    Summary
    Added the line '2016 ( U.S. NIH Grant/Contract )' to the study's identifiers, indicating an NIH funding reference in the Other Study ID Numbers section.
    Difference
    0.0%
    Check dated 2026-08-24T16:36:41.000Z thumbnail image
  7. Check
    76 days ago
    Change Detected
    Summary
    A new page revision label Revision: v3.6.5 appears, replacing the prior label Revision: v3.6.4. This indicates a new build of the page was published, typically for maintenance or minor fixes.
    Difference
    0.0%
    Check dated 2026-08-10T06:51:54.000Z thumbnail image

Stay in the know with updates to Nab-Paclitaxel/Gemcitabine±Olaratumab in Metastatic Pancreatic Ca Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nab-Paclitaxel/Gemcitabine±Olaratumab in Metastatic Pancreatic Ca Clinical Trial page.